Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9299)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2015 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Seicean A, Petrusel L, Seicean R. New targeted therapies in pancreatic cancer. World J Gastroenterol 2015; 21(20): 6127-6145 [PMID: 26034349 DOI: 10.3748/wjg.v21.i20.6127] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v21/i20/6127.htm |
| Number | Citing Articles |
| 1 |
Qiangbo Zhang, Hong Wang, Lin Ran, Zongli Zhang, Runde Jiang. The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent. Biochemical and Biophysical Research Communications 2016; 476(4): 260 doi: 10.1016/j.bbrc.2016.05.106
|
| 2 |
K. Hemanth Kumar, Shallu Garg, Thakur Deen Yadav, Daisy Sahni, Harsimranjit Singh, Rajinder Singh. Anatomy of peripancreatic arteries and pancreaticoduodenal arterial arcades in the human pancreas: a cadaveric study. Surgical and Radiologic Anatomy 2021; 43(3): 367 doi: 10.1007/s00276-020-02632-2
|
| 3 |
Umut Fahrioğlu, Yavuz Dodurga, Levent Elmas, Mücahit Seçme. Ferulic acid decreases cell viability and colony formation while inhibiting migration of MIA PaCa-2 human pancreatic cancer cells in vitro. Gene 2016; 576(1): 476 doi: 10.1016/j.gene.2015.10.061
|
| 4 |
Priyanka Gupta, Pedro A. Pérez-Mancera, Hemant Kocher, Andrew Nisbet, Giuseppe Schettino, Eirini G. Velliou. A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma—Toward a Better Mimicry of the in vivo Tumor Microenvironment. Frontiers in Bioengineering and Biotechnology 2020; 8 doi: 10.3389/fbioe.2020.00290
|
| 5 |
Sheng Chen, Ye Wang, Wen-Long Zhang, Mao-Sheng Dong, Jian-Hua Zhang. Sclareolide enhances gemcitabine-induced cell death through mediating the NICD and Gli1 pathways in gemcitabine-resistant human pancreatic cancer. Molecular Medicine Reports 2017; 15(4): 1461 doi: 10.3892/mmr.2017.6182
|
| 6 |
Wenbin Li, Yue Zhu, Kelin Zhang, Xianhuan Yu, Haoming Lin, Wenrui Wu, Yaorong Peng, Jian Sun. PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer. Experimental & Molecular Medicine 2020; 52(3): 409 doi: 10.1038/s12276-020-0390-4
|
| 7 |
Jian-Nan Li, Wei Li, Lan-Qing Cao, Ning Liu, Kai Zhang. Efficacy of mesenchymal stem cells in the treatment of gastrointestinal malignancies. World Journal of Gastrointestinal Oncology 2020; 12(4): 365-382 doi: 10.4251/wjgo.v12.i4.365
|
| 8 |
Matthew D Johnson, Brandon Stone, Bryan J Thibodeau, Andrew M Baschnagel, Sandra Galoforo, Laura E Fortier, Billie Ketelsen, Samreen Ahmed, Zakiya Kelley, Alaa Hana, Thomas G Wilson, John M Robertson, Robert P Jury, George D Wilson. The significance of Trk receptors in pancreatic cancer. Tumor Biology 2017; 39(2): 101042831769225 doi: 10.1177/1010428317692256
|
| 9 |
Lutian Yao, Mengyi Wang, Zheyu Niu, Qiaofei Liu, Xiang Gao, Li Zhou, Quan Liao, Yupei Zhao. Interleukin-27 inhibits malignant behaviors of pancreatic cancer cells by targeting M2 polarized tumor associated macrophages. Cytokine 2017; 89: 194 doi: 10.1016/j.cyto.2015.12.003
|
| 10 |
I. SZADVARI, O. KRIZANOVA, P. BABULA. Athymic Nude Mice as an Experimental Model for Cancer Treatment. Physiological Research 2016; : S441 doi: 10.33549/physiolres.933526
|
| 11 |
Jiali Ma, Pingping Hui, Wenying Meng, Na Wang, Shihao Xiang. Ku70 inhibits gemcitabine-induced DNA damage and pancreatic cancer cell apoptosis. Biochemical and Biophysical Research Communications 2017; 484(4): 746 doi: 10.1016/j.bbrc.2017.01.146
|
| 12 |
Priyanka Gupta, Camino Bermejo‐Rodriguez, Hemant Kocher, Pedro A. Pérez‐Mancera, Eirini G. Velliou. Chemotherapy Assessment in Advanced Multicellular 3D Models of Pancreatic Cancer: Unravelling the Importance of Spatiotemporal Mimicry of the Tumor Microenvironment. Advanced Biology 2024; doi: 10.1002/adbi.202300580
|
| 13 |
Amit Singh, Jing Xu, George Mattheolabakis, Mansoor Amiji. EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model. Nanomedicine: Nanotechnology, Biology and Medicine 2016; 12(3): 589 doi: 10.1016/j.nano.2015.11.010
|
| 14 |
Xiao Liu, Xueliang Xia, Chenghai Sun, Cai Lin, Yiqian Zhou, Muzammal Hussain, Fei Tang, Lu Liu, Xue Li, Jiancun Zhang. Synthesis and Evaluation of 2′-Deoxy-2′-Spirodiflurocyclopropyl Nucleoside Analogs. Nucleosides, Nucleotides and Nucleic Acids 2016; 35(9): 479 doi: 10.1080/15257770.2016.1202965
|
| 15 |
Matthew T. Basel, Sanjeev Narayanan, Chanran Ganta, Tej B. Shreshta, Alejandro Marquez, Marla Pyle, Jennifer Hill, Stefan H. Bossmann, Deryl L. Troyer. Developing a xenograft human tumor model in immunocompetent mice. Cancer Letters 2018; 412: 256 doi: 10.1016/j.canlet.2017.10.009
|
| 16 |
Anna M. Knapinska, Christie-Anne Estrada, Gregg B. Fields. Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Target Tissues and Therapy. Progress in Molecular Biology and Translational Science 2017; 148: 339 doi: 10.1016/bs.pmbts.2017.03.004
|
| 17 |
Andrea Marie Ibrahim, Yao-He Wang. Viro-immune therapy: A new strategy for treatment of pancreatic cancer. World Journal of Gastroenterology 2016; 22(2): 748-763 doi: 10.3748/wjg.v22.i2.748
|
| 18 |
Olivier Placide Noté, Sarah Ali Azouaou, Line Simo, Cyril Antheaume, Dominique Guillaume, Dieudonné Emmanuel Pegnyemb, Christian Dominique Muller, Annelise Lobstein. Phenotype-specific apoptosis induced by three new triterpenoid saponins from Albizia glaberrima (Schumach. & Thonn.) Benth. Fitoterapia 2016; 109: 80 doi: 10.1016/j.fitote.2015.12.012
|
| 19 |
Shikhar Mehrotra, Carolyn D. Britten, Steve Chin, Elizabeth Garrett-Mayer, Colleen A. Cloud, Mingli Li, Gina Scurti, Mohamed L. Salem, Michelle H. Nelson, Melanie B. Thomas, Chrystal M. Paulos, Andres M. Salazar, Michael I. Nishimura, Mark P. Rubinstein, Zihai Li, David J. Cole. Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. Journal of Hematology & Oncology 2017; 10(1) doi: 10.1186/s13045-017-0459-2
|
| 20 |
Xiaoguang Zhao, Baoyou Sun, Jingjing Zhang, Ruishen Zhang, Qing Zhang. Short-chain C6 ceramide sensitizes AT406-induced anti-pancreatic cancer cell activity. Biochemical and Biophysical Research Communications 2016; 479(2): 166 doi: 10.1016/j.bbrc.2016.08.121
|
| 21 |
Fan Lei, Xinyuan Xi, Surinder K. Batra, Tatiana K. Bronich. Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer. Journal of Pharmacology and Experimental Therapeutics 2019; 370(3): 682 doi: 10.1124/jpet.118.255786
|
| 22 |
Dexiang Zhang, Yuedi Dai, Yuankun Cai, Tao Suo, Han Liu, Yueqi Wang, Zhijian Cheng, Houbao Liu. PEBP4 promoted the growth and migration of cancer cells in pancreatic ductal adenocarcinoma. Tumor Biology 2016; 37(2): 1699 doi: 10.1007/s13277-015-3906-0
|
| 23 |
Yongsheng Jiang, Qinghua Meng, Bo Chen, Haiyu Shen, Bing Yan, Baoyou Sun. The small-molecule IAP antagonist AT406 inhibits pancreatic cancer cells in vitro and in vivo. Biochemical and Biophysical Research Communications 2016; 478(1): 293 doi: 10.1016/j.bbrc.2016.07.011
|
| 24 |
Yihui Sun, Jiaming Xie, Shang Cai, Qian Wang, Zhenyu Feng, Yecheng Li, Jing-jing Lu, Wei Chen, Zhenyu Ye. Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth. Cell Death & Disease 2021; 12(10) doi: 10.1038/s41419-021-04205-6
|
| 25 |
N. A. Mitkin, A. S. Ustiugova, A. N. Uvarova, K. A. Rumyantsev, K. V. Korneev, V. V. Pavshintsev. Serum of Mice Immunized with MT1-MMP Metalloproteinase Reduces Migration Potential of Pancreatic Cancer Cells. Molecular Biology 2021; 55(6): 910 doi: 10.1134/S0026893321050095
|
| 26 |
Wenhua He, Qingxuan Li, Yan Lu, Dingyue Ju, Yu Gu, Kai Zhao, Chuanming Dong. Cancer Treatment Evolution from Traditional Methods to Stem Cells and
Gene Therapy. Current Gene Therapy 2022; 22(5): 368 doi: 10.2174/1566523221666211119110755
|
| 27 |
Shi-qing Peng, Xiao-ren Zhu, Ming-zhi Zhao, Yi-fan Zhang, An-ran Wang, Min-bin Chen, Zhen-yu Ye. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer. Cell Death & Disease 2023; 14(2) doi: 10.1038/s41419-023-05684-5
|
| 28 |
Cindy Serdjebi, Florence Gattacceca, Jean-François Seitz, Francine Fein, Johan Gagnière, Eric François, Abakar Abakar-Mahamat, Gael Deplanque, Madani Rachid, Bruno Lacarelle, Joseph Ciccolini, Laetitia Dahan. Population Pharmacokinetics of Gemcitabine and dFdU in Pancreatic Cancer Patients Using an Optimal Design, Sparse Sampling Approach. Therapeutic Drug Monitoring 2017; 39(3): 290 doi: 10.1097/FTD.0000000000000399
|
| 29 |
Jonas R.M. Van Audenaerde, Geert Roeyen, Phillip K. Darcy, Michael H. Kershaw, M. Peeters, Evelien L.J. Smits. Natural killer cells and their therapeutic role in pancreatic cancer: A systematic review. Pharmacology & Therapeutics 2018; 189: 31 doi: 10.1016/j.pharmthera.2018.04.003
|
| 30 |
Maryum Nisar, Rehan Zafar Paracha, Iqra Arshad, Sidra Adil, Sabaoon Zeb, Rumeza Hanif, Mehak Rafiq, Zamir Hussain. Integrated Analysis of Microarray and RNA-Seq Data for the Identification of Hub Genes and Networks Involved in the Pancreatic Cancer. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.663787
|
| 31 |
Yu-Xiao Yang, Anil K. Rustgi. Impact of Metformin on Advanced Pancreatic Cancer Survival: Too Little, Too Late?. Clinical Cancer Research 2016; 22(5): 1031 doi: 10.1158/1078-0432.CCR-15-2494
|
| 32 |
SHIYUAN SONG, YING WANG, PO XU, RUINA YANG, ZHIKUN MA, SHUO LIANG, GUANGPING ZHANG. The inhibition of histone deacetylase 8 suppresses proliferation and inhibits apoptosis in gastric adenocarcinoma. International Journal of Oncology 2015; 47(5): 1819 doi: 10.3892/ijo.2015.3182
|
| 33 |
Melissa Gallery, Julie Zhang, Daniel P. Bradley, Pamela Brauer, Donna Cvet, Jose Estevam, Hadi Danaee, Edward Greenfield, Ping Li, Mark Manfredi, Huay-Keng Loke, Claudia Rabino, Brad Stringer, Mark Williamson, Tim Wyant, Johnny Yang, Qing Zhu, Adnan Abu-Yousif, O. Petter Veiby, Hiroshi Shiku. A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo. PLOS ONE 2018; 13(1): e0191046 doi: 10.1371/journal.pone.0191046
|